Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States
Dr. Chhatriwalla is an Interventional Cardiologist and Clinical Scholar, Medical Director of Structural Intervention and Director of Interventional Research at Saint Luke’s Mid America Heart Institute, and a Professor of Medicine at the University of Missouri-Kansas City. He specializes in coronary and structural intervention.
Dr. Chhatriwalla received his medical degree from Case Western Reserve University School of Medicine in Cleveland, OH. He completed an Internal Medicine residency at the University of Virginia in Charlottesville, VA and Cardiology and Interventional Cardiology fellowships at the Cleveland Clinic in Cleveland, OH.
Disclosure(s): Abbott Medical: Speakers' Bureau (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Independent Contractor (Ongoing), Speakers' Bureau (Ongoing); Medtronic Inc: Consultant (Ongoing), Independent Contractor (Ongoing), Speakers' Bureau (Ongoing)
STS/ACC TVT Registry: Do Operator Volume Matters for Mitral Valve Repair?
Saturday, March 9, 2024
10:14 AM – 10:22 AM ET
Live Case from Los Robles Regional Medical Center | Los Angeles, CA
Saturday, March 9, 2024
11:02 AM – 11:52 AM ET
CRT 2024 | Faculty Assignment [ECON]
Saturday, March 9, 2024
9:00 AM – 9:00 PM ET
Panel Discussion | Lifetime Management Post TAVR and Valve-in-Valve
Saturday, March 9, 2024
5:56 PM – 6:15 PM ET
Sunday, March 10, 2024
4:31 PM – 4:39 PM ET
Live Case from Piedmont Hospital | Atlanta, Georgia
Monday, March 11, 2024
8:00 AM – 8:55 AM ET
Live Case from Medizinische Klinik, St. Johannes Hospital Dortmund | Dortmund, Germany
Monday, March 11, 2024
8:55 AM – 9:40 AM ET
Bioprosthetic Valve Fracture: When and How?
Monday, March 11, 2024
4:30 PM – 4:38 PM ET
Pitfalls in the Use of TAVR for Aortic Regurgitation
Tuesday, March 12, 2024
9:06 AM – 9:14 AM ET
Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Approved in the US Yet
Tuesday, March 12, 2024
10:18 AM – 10:30 AM ET